SCHEMBL5173769

SCHEMBL5173769

O=C(Cc1ccc(OCCN2CCCCC2)cc1)Nc1ccccc1O

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 2/20 0.54
▸ LTA4H P09960 5/20 0.54
▸ CCNA2 P20248 1/20 0.54
▸ CDK2 P24941 1/20 0.54
▸ CCNA1 P78396 1/20 0.54
▸ HTT P42858 1/20 0.53
▸ MCHR1 Q99705 2/20 0.52
▸ MAPK8 P45983 2/20 0.52
▸ MAPK9 P45984 2/20 0.52
▸ MAPK10 P53779 2/20 0.52
▸ PSMB1 P20618 2/20 0.52
▸ PSMB5 P28074 2/20 0.52
▸ PSMB2 P49721 2/20 0.52
▸ HRH3 Q9Y5N1 2/20 0.51
▸ KCNQ2 O43526 1/20 0.51
▸ KCNA5 P22460 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5175416 0.85 LTA4H (0.50) EPHX2LTA4HCCNA2CDK2CCNA1
SCHEMBL2741675 0.77 PSMB1 (0.68) LTA4HHTTPSMB1PSMB5PSMB2
SCHEMBL2741674 0.77 PSMB1 (0.68) LTA4HHTTPSMB1PSMB5PSMB2
SCHEMBL12315758 0.76 KDM4E (0.63) LTA4HHTTPSMB1PSMB5PSMB2
SCHEMBL11154787 0.76 PSMB1 (0.66) LTA4HHTTPSMB1PSMB5PSMB2
Hydrochloric Acid SCHEMBL228735 0.76 PSMB1 (0.66) LTA4HHTTPSMB1PSMB5PSMB2
Hydrochloric Acid SCHEMBL228395 0.76 PSMB1 (0.66) LTA4HHTTPSMB1PSMB5PSMB2
SCHEMBL4092312 0.76 PSMB1 (0.66) LTA4HHTTPSMB1PSMB5PSMB2
SCHEMBL7240783 0.75 PSMB1 (0.65) LTA4HHTTPSMB1PSMB5PSMB2
SCHEMBL25940273 0.74 LTA4H (0.62) LTA4HHTTPSMB1PSMB5PSMB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 — — EP claimed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — WO claimed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — US claimed
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 — — EP disclosed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — WO disclosed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators LTA4H, LTB4R, LTC4S EPHX2 98/4885LTA4H 1/4885CCNA2 3339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback